References
- Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhasz I, Lapins J, Matusiak L, Prens EP, Revuz J, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015;29:619–44. doi:https://doi.org/10.1111/jdv.12966.
- Jemec GB, Heidenheim M, Nielsen NH. Hidradenitis suppurativa–characteristics and consequences. Clin Exp Dermatol. 1996;21:419–23. doi:https://doi.org/10.1111/j.1365-2230.1996.tb00145.x.
- Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, Poli F, Faye O, Roujeau JC, Bonnelye G, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol. 2008;59:596–601. doi:https://doi.org/10.1016/j.jaad.2008.06.020.
- Cosmatos I, Matcho A, Weinstein R, Montgomery MO, Stang P. Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. J Am Acad Dermatol. 2013;68:412–19. doi:https://doi.org/10.1016/j.jaad.2012.07.027.
- van der Zee HH, van der Woude CJ, Florencia EF, Prens EP. Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study. Br J Dermatol. 2010;162:195–97. doi:https://doi.org/10.1111/j.1365-2133.2009.09430.x.
- Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60:539–61. doi:https://doi.org/10.1016/j.jaad.2008.11.911.
- Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol. 2005;17:586–99. doi:https://doi.org/10.1097/bor.0000174210.78449.6b.
- Perera GK, Di Meglio P, Nestle FO. Psoriasis. Annu Rev Pathol. 2012;7:385–422. doi:https://doi.org/10.1146/annurev-pathol-011811-132448.
- van der Zee HH, de Ruiter L, van den Broecke DG, Dik WA, Laman JD, Prens EP. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. Br J Dermatol. 2011;164:1292–98. doi:https://doi.org/10.1111/j.1365-2133.2011.10254.x.
- Kristensen M, Chu CQ, Eedy DJ, Feldmann M, Brennan FM, Breathnach SM. Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor. Clin Exp Immunol. 1993;94:354–62. doi:https://doi.org/10.1111/j.1365-2249.1993.tb03457.x.
- Lima AL, Karl I, Giner T, Poppe H, Schmidt M, Presser D, Goebeler M, Bauer B. Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. Br J Dermatol. 2016;174:514–21. doi:https://doi.org/10.1111/bjd.14214.
- Keijsers RR, Joosten I, van Erp PE, Koenen HJ. van de Kerkhof PC. Cellular sources of IL-17 in psoriasis: a paradigm shift? Exp Dermatol. 2014;23:799–803. doi:https://doi.org/10.1111/exd.12487.
- Sanchez J, Le Jan S, Muller C, François C, Renard Y, Durlach A, Bernard P, Reguiai Z, Antonicelli F. Matrix remodeling and MMP expression/activation is associated with hidradenitis suppurativa skin inflammation. Exp Dermatol. 2019;28:593–600. doi:https://doi.org/10.1111/exd.13919.
- Suomela S, Kariniemi AL, Snellman E, Saarialho-Kere U. Metalloelastase (MMP-12) and 92-kDa gelatinase (MMP-9) as well as their inhibitors, TIMP-1 and −3, are expressed in psoriatic lesions. Exp Dermatol. 2001;10:175–83. doi:https://doi.org/10.1034/j.1600-0625.2001.010003175.x.
- Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001;17:463–516. doi:https://doi.org/10.1146/annurev.cellbio.17.1.463.
- Geerling G, Joussen AM, Daniels JT, Mulholland B, Khaw PT, Dart JK. Matrix metalloproteinases in sterile corneal melts. Ann N Y Acad Sci. 1999;878:571–74. doi:https://doi.org/10.1111/j.1749-6632.1999.tb07730.x.
- Daniels JT, Geerling G, Alexander RA, Murphy G, Khaw PT, Saarialho-Kere U. Temporal and spatial expression of matrix metalloproteinases during wound healing of human corneal tissue. Exp Eye Res. 2003;77:653–64. doi:https://doi.org/10.1016/j.exer.2003.08.010.
- Luo L, Li DQ, Corrales R, Pflugfelder SC. Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens. 2005;31:186–93. doi:https://doi.org/10.1097/01.ICL.0000162759.79740.46.
- Tomlinson A, Khanal S, Ramaesh K, Diaper C, McFadyen A. Tear film osmolarity: determination of a referent for dry eye diagnosis. IOVS. 2006;47:4309–15.
- Her Y, Lim JW, Han SH. Dry eye and tear film functions in patients with psoriasis. Jpn J Ophthalmol. 2013;57:341–46. doi:https://doi.org/10.1007/s10384-012-0226-4.
- Demirci G, Erdur SK, Aydin R, Balevi A, Eliacik M, Ozsutcu M, Olmuscelik O. Tear osmolarity and ocular surface parameters in patients with psoriasis. Arg Bras Oftalmol. 2017;80:1–3.
- Aragona E, Rania L, Postorino EI, Interdonato A, Giuffrida R, Cannavò SP, Puzzolo D, Aragona P. Tear film and ocular surface assessment in psoriasis. Br J Ophthalmol. 2018;102:302–08. doi:https://doi.org/10.1136/bjophthalmol-2017-310307.
- Saygin D, US A, CY L, Srivastava S, Maya JJ. Characteristics of inflammatory eye disease associated with hidradenitis suppurativa. Eur J Rheumatol. 2018;5:165–68. doi:https://doi.org/10.5152/eurjrheum.2018.17163.
- Rosen DB, Moshirfar M, Heiland MB, Ronquillo YC, Hoopes PC. Should patients with Hidradenitis Suppurativa undergo LASIK? Ophthalmol Ther. 2019;8:353–59. doi:https://doi.org/10.1007/s40123-019-0201-y.
- Lee DJ, Desai S, Laurent E, Kopplin LJ. Characterization and management of inflammatory eye disease in patients with hidradenitis suppurativa. Ocul Immunol Inflamm. 2020:1–6. [ Online ahead of print].
- Kramann C, Boehm N, Lorenz K, Wehrwein N, Stoffelns BM, Pfeiffer N, Grus FH. Effect of contact lenses on the protein composition in tear film: a ProteinChip study. Graefes Arch Clin Exp Ophthalmol. 2011;249:233–43. doi:https://doi.org/10.1007/s00417-010-1456-0.
- Schargus M, Ivanova S, Kakkassery V, Dick HB, Joachim S. Correlation of tear film osmolarity and 2 different MMP-9 tests with common dry eye tests in a cohort of non-dry eye patients. Cornea. 2015;34:739–44. doi:https://doi.org/10.1097/ICO.0000000000000449.
- Hurley H. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. In: Roenigh RRH, editor. Dermatologic surgery. New York, NY: Marcel Dekker; 1989. p. 729–39.
- Grant A, Gonzalez T, Montgomery MO, Cardenas V, Kerdel FA. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. J Am Acad Dermatol. 2010;62:205–17. doi:https://doi.org/10.1016/j.jaad.2009.06.050.
- Fredricksson T, Pettersson U. Severe psoriasis—oral therapy with a new retinoid. Dermatologica. 1978;157:238–44. doi:https://doi.org/10.1159/000250839.
- Finis D, Pischel N, Schrader S, Geerling G. Evaluation of lipid layer thickness measurement of the tear film as a diagnostic tool for meibomian gland dysfunction. Cornea. 2013;32:1549–53. doi:https://doi.org/10.1097/ICO.0b013e3182a7f3e1.
- Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640–50. doi:https://doi.org/10.1097/00003226-200310000-00008.
- Tsubota K, Yokoi N, Watanabe H, Dogru M, Kojima T, Yamada M, Kinoshita S, Kim HM, Tchah HW, Hyon JY, et al. A new perspective on dry eye classification: proposal by the Asia dry eye society. Eye Contact Lens. 2019 Aug 13. [ Online ahead of print].
- Shimazaki J. Definition and diagnostic criteria of dry eye disease: historical overview and future directions. Invest Opthalmol Vis Sci. 2018;59:DES7–DES12. doi:https://doi.org/10.1167/iovs.17-23475.
- Malakouti M, Brown GE, Wang E, Koo J, Levin EC. The role of IL-17 in psoriasis. J Dermatolog Treat. 2015;26:41–44. doi:https://doi.org/10.3109/09546634.2013.879093.
- Cordero-Coma M, Anzaar F, Sobrin L, Foster CS. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. Ocul Immunol Inflamm. 2007;15:99–104. doi:https://doi.org/10.1080/09273940701299354.
- Meskin SW, Carlson EM. Mooren’s-type ulceration associated with severe hidradenitis suppurativa: a case report and literature review. Ocul Immunol Inflamm. 2011;19:340–42. doi:https://doi.org/10.3109/09273948.2011.584653.
- Alzaga Fernandez AG, Demirci H, Darnley-Fisch DA, Steen DW. Interstitial keratitis secondary to severe hidradenitis suppurativa: a case report and literature review. Cornea. 2010;29:1189–91. doi:https://doi.org/10.1097/ICO.0b013e3181d4fd5c.
- Arriola-Villalobos P, Díaz-Valle D, Alejandre-Alba N, López-Abad C, Méndez-Fernández R, Benítez-del-Castillo JM. Bilateral Candida chorioretinitis following etanercept treatment for hidradenitis suppurativa. Eye (Lond). 2008;22:599–600. doi:https://doi.org/10.1038/sj.eye.6703100.
- Rehal B, Modjtahedi BS, Morse LS, Schwab IR, Maibach HI. Ocular psoriasis. J Am Acad Dermatol. 2011;65:1202–12
- Ghalamkarpour F, Baradaran-Rafii A, Sadoughi MM, Abdollahimajd F, Younespour S, Zargari O, Rudolph RI. Ocular findings in patients with psoriasis: is it related to the side effects of treatment or to psoriasis itself? A case-control study. J Dermatol Treat. 2011;31:27–37.
- Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 2000;14:163–76.
- Sivak JM, Fini ME. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res. 2002;21:1–14. doi:https://doi.org/10.1016/S1350-9462(01)00015-5.
- Kaufman HE. The practical detection of mmp-9 diagnoses ocular surface disease and may help prevent its complications. Cornea. 2013;32:211–16. doi:https://doi.org/10.1097/ICO.0b013e3182541e9a.
- Chotikavanich S, de Paiva CS, de Li Q, Chen JJ, Bian F, Farley WJ, Pflugfelder SC. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci. 2009;50:3203–09. doi:https://doi.org/10.1167/iovs.08-2476.
- Mauris J, Woodward AM, Cao Z, Panjwani N, Argüeso P. Molecular basis for MMP9 induction and disruption of epithelial cell-cell contacts by galectin-3. J Cell Sci. 2014;127:3141–48. doi:https://doi.org/10.1242/jcs.148510.
- Van der Meid KR, Su SP, Ward KW, Zhang JZ. Correlation of tear inflammatory cytokines and matrix metalloproteinases with four dry eye diagnostic tests. Invest Ophthalmol Vis Sci. 2012;53:1512–18. doi:https://doi.org/10.1167/iovs.11-7627.
- Tan X, Sun S, Liu Y, Zhu T, Wang K, Ren T, Wu Z, Xu H, Zhu L. Analysis of Th17-associated cytokines in tears of patients with dry eye syndrome. Eye (Lond). 2014;28:608–13. doi:https://doi.org/10.1038/eye.2014.38.
- Liu R, Gao C, Chen H, Li Y, Jin Y, Qi H. Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease. PLoS One. 2017;12:e0173301. doi:https://doi.org/10.1371/journal.pone.0173301.
- Kang MH, Kim MK, Lee HJ, Lee HI, Wee WR, Lee JH. Interleukin-17 in various ocular surface inflammatory diseases. J Korean Med Sci. 2011;26:938–44. doi:https://doi.org/10.3346/jkms.2011.26.7.938.
- Acera A, Rocha G, Vecino E, Lema I, Durán JA. Inflammatory markers in the tears of patients with ocular surface disease. Ophthalmic Res. 2008;40:315–21. doi:https://doi.org/10.1159/000150445.